Stock & Company Details
IN8bio Inc $INAB
Price:
46,691,331
9.8M
$14M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
INAB technical indicators
Latest IN8bio Inc (INAB) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
45.21 2.2%
MACD:
-0.04 5.3%
SMA 50:
$1.53 0.1%
SMA 200:
$1.80 0.2%
EMA 20:
$1.45 0.2%
Bollinger Bands:
1.53 / 1.34
Stochastic:
47.62 25.0%
ADX 14:
12.75 5.7%
ATR 14:
0.09 3.1%
CCI 20:
-36.73 33.9%
OBV:
-2.72M 0.6%
ROC 12:
-0.70% 66.4%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
Signal:
Volatility: High
Sentiment:
Finance Bot
🤖
Ask your questions
Start by typing a question below.
